BRITS are being urged to look out for symptoms of RSV after an increase in cases of the highly contagious disease. The virus ...

An infant immunization for respiratory syncytial virus (RSV) is now available across Canada, but it still has to be paid for ...

As several European countries are currently detecting respiratory syncytial virus (RSV) infections, ECDC issues rapid ...

ECDC advocates for execution of respiratory syncytial virus (RSV) immunization programs including maternal vaccines to protect infants from severe hospitalization.

Two new studies suggest that nirsevimab (Beyfortus) is 80% to 89% effective in protecting infants from poor respiratory ...

Respiratory Syncytial Virus (RSV) is a common virus in babies and often starts with mild cold-like symptoms. For some infants ...

Expecting mothers face heightened health risks during winter due to reduced immunity and increased viral exposure. Closed ...

The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.

This is read by an automated voice. Please report any issues or inconsistencies here. The leading cause of infant hospitalization, RSV can trigger severe pneumonia and lung infections. Health ...

Respiratory syncytial virus (RSV) is a common respiratory virus which usually causes mild, cold-like symptoms during the ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing ...

FARGO — Pediatricians at Sanford Health say a recently developed method of protecting babies from RSV showed incredible results. Dr. Stephanie Hanson said last season was the first time a “monoclonal ...